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OBJECTIVE — To determine whether glycemic control is improving in diabetic children in
Wales and to identify factors associated with improvement.
RESEARCH DESIGN AND METHODS — Data were collected in 2001 and 2006.
RESULTS — Over time A1C was reduced from 9.08  1.66 to 8.88  1.63% (P  0.012).
Thereweredifferencesamongcenters(P0.001)anddifferentialchangesovertime(interaction
P  0.001). Since 2001 ﬁve centers had appointed a pediatric diabetes specialist nurse (PDSN).
A1Cimprovedinthesecentersfrom9.591.88to8.721.61%(P0.001).Glycemiccontrol
was worse in children aged 10 years compared with younger patients (P  0.001). Improve-
ment occurred in those aged 10 years. Age (P  0.003) and insulin dose (P  0.001) were
positively and independently associated with A1C. Thus, any inﬂuence of PDSNs was not
achieved through increased insulin prescription.
CONCLUSIONS — Improvement in glycemic control has occurred. Worse control is asso-
ciated with greater prescribed insulin dose in older children. Appointment of PDSNs was asso-
ciated with improved glycemic control among adolescents.
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W
hether glycemic control in chil-
dren with type 1 diabetes is
improving with modern man-
agementiscontroversial.Weaimedtode-
termine whether control has improved in
Wales and to identify factors related to
improvement. Between 2001 and 2006
ﬁvecentersappointedapediatricdiabetes
specialist nurse (PDSN), allowing exami-
nationofchangesassociatedwiththisser-
vice development. We assessed glycemic
control over time by center, age-group,
insulin regimen, and sex.
RESEARCH DESIGN AND
METHODS— Twelve of 14 pediatric
diabetes units in Wales supplied data col-
lected at routine clinic visits within 3
months of November 2001 and Novem-
ber2006.Patientswere99%whiteaged
up to 18 years. Age-standardized weight
measurements are from U.K. national
growth standards (1). Five centers ap-
pointed PDSNs after 2001, having not
had one previously. The remaining seven
centers, except for the smallest, already
had PDSNs. Ascertainment calculation
denominator data came from the Brecon
Groupregister,anall-Walesregisterofdi-
abetic children.
The inﬂuence of center, age-group,
and appointment of a PDSN on A1C over
time was analyzed in separate ANOVA
models(Tukeyhonestlysigniﬁcantdiffer-
enceposthoctest).Incomparisonofcen-
ters, A1C data were adjusted for age, sex,
and body weight. Multilinear regression
(backwards stepwise) was used to assess
the inﬂuence of age, sex, PDSN, insulin
dose (units per kilogram per day) and
number of daily doses on A1C. Because
the last of these parameters was only
available for the 2006 dataset, the initial
analysis was undertaken using 2006 data
only(n795)andthenasecondanalysis
without number of daily doses was per-
formed with 2001 and 2006 data (n 
1,689). Data are reported as means SD.
RESULTS— The proportion of Welsh
diabetic children included was 80% in
2001 and 88% in 2006. In 2006 patients
were heavier, but A1C was lower (Table
1). Diabetic children were 0.60 SD above
mean weight for age in 2001, increasing
to 0.72 SD in 2006. Insulin dose in-
creased in proportion to weight. A1C was
not different by sex (boys 8.96  1.63%
and girls 9.05  1.67%, P  0.21).
Adjusted A1C from the 12 centers
varied from 8.45  1.57 to 10.33 
1.57% in 2001 and from 8.10  1.56 to
9.30  1.58% in 2006. ANOVA demon-
strated differences among centers (P 
0.001) and over time (P  0.001) and
differential change among centers over
time (interaction P  0.001). Four cen-
ters showed improvement, one was bor-
derline (P  0.053), ﬁve showed no
change, and in two A1C deteriorated.
Glycemic control was worse in chil-
dren aged 10 years compared with
those aged 5–9 years (P  0.001) and 5
years (P  0.001) (Table 1). In a three-
wayANOVA(year,newPDSN,andage
or 10 years), there was interaction be-
tween year and age-group (F  3.96, P 
0.047),indicatingthatchildrenaged10
yearsshowedimprovementin2006com-
pared with 2001.
In centers appointing a PDSN, A1C
improved versus that in those with no
stafﬁng change (center vs. time interac-
tion P  0.001). Centers that appointed a
PDSN were those with the highest mean
A1C, raising the possibility that regres-
sion to the mean contributed to reduced
A1C in this subgroup. Therefore, ex-
pected regression to the mean was calcu-
lated from the variance in 2001 center
A1C means (2). Repeating the analysis
with 2001 center means corrected for ex-
pected regression to the mean conﬁrmed
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0.007).Useofindividualpatientdataalso
showed a center versus time interaction
(P  0.001) (Table 1). Appointment of a
PDSN did not affect body weight or insu-
lin dose (units per kilogram per day).
None of the ﬁve new appointments
was associated with additional pediatri-
cian clinics. Three appointees started
nurse-led clinics seeing patients between
doctor appointments. All reported in-
creasedtelephonecontactsandhomeand
school visits with more frequent insulin
doseadjustments,changeofregimen,and
diabeteseducation.Fewpatientswereus-
ing insulin pumps (1% in 2006). For-
mal “dose adjustment for normal eating”
(DAFNE-type)programswerenotthenin
use.
Multivariate analysis indicated that
number of insulin doses per day bore no
relation to A1C. Age (0.15, P 
0.001), insulin dose in units per kilogram
per day (0.16, P  0.001), and the
presence of a PDSN ( 0.12, P 
0.001) were independently associated
with A1C (adjusted R
2  0.07, F  43.1,
P  0.001), whereas sex was not. Simple
linear regression showed no correlation
betweennumberofpatientsseenatacen-
ter and mean A1C either in 2001 (r 
0.18, P  0.58) or 2006 (r  0.26, P 
0.41).
CONCLUSIONS — Missing data
weredistributedamongcontributingcen-
ters and patient subgroups at random
with no systematic bias. A high propor-
tion of diabetic children were included.
We therefore feel that the aggregate data
are representative of glycemic control in
Welsh children with type 1 diabetes. A1C
here was similar to that in Northern Ire-
land (8.8%), Scotland (8.9%), France
(9.0%), and Denmark (8.7%) (3–6). We
identiﬁed modest improvement in glyce-
mic control over time.
Wefoundnoeffectofsexonglycemic
control. The Hvidøre study found higher
A1Cingirls(7),butothersstudiesdidnot
(8,9). Adolescent girls have more ketoac-
idosis (10,11), but overall the sex differ-
ence is minimal. In 2006 more insulin
was prescribed in proportion to children
being heavier. Body weight in our cohort
was above the 50th centile for U.K. chil-
dren in 2001 and greater in 2006 and is
cause for concern. Elevated BMI has pre-
viously been demonstrated in diabetic
children (12).
ThedifferencesinA1Camongcenters
were striking. The Hvidøre study also
identiﬁed differences among centers,
which were persistent and largely unex-
plained(13).Asinthatstudy,ourdatado
not indicate that multiple injection regi-
mens are superior (13,14). We included
smallandlargecenters,butnumbersseen
did not relate to A1C achieved. However,
improved glycemic control occurred in
centers where a PDSN had been ap-
pointed. Greater prescribed insulin dose
was associated with worse control inde-
pendentlyofageandPDSN.Thus,PDSNs
did not gain improved control through
advising more insulin. It seems likely that
prescribers recommended more insulin
in response to rising A1C from reduced
compliance. Nurses generated increased
contacts between clinic and child/family.
Their supportive and educational role
may achieve better glycemic control.
Their application of other developments
in care might also contribute. Children
aged 10 years were the ones who
showed improvement. PDSNs may inﬂu-
ence adverse behavioral factors operative
in adolescence.
In 2001, Welsh centers without
PDSNs mostly had sessions of time from
adult diabetes nurses. The presence of
PDSNs reduces median length of stay for
children with newly diagnosed diabetes
and reduces clinic nonattendance (15).
Our study suggests an inﬂuence on A1C.
We speculate that the beneﬁt occurred
fromimprovedself-careinolderchildren.
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